These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10993007)

  • 1. [Treatment with beta blockers in advanced heart failure].
    Gronda E; Bologna A; Mangiavacchi M; Andreuzzi B
    Ital Heart J Suppl; 2000 Aug; 1(8):1011-8. PubMed ID: 10993007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta blocker therapy for chronic heart failure.
    Ramahi TM
    Am Fam Physician; 2000 Nov; 62(10):2267-74. PubMed ID: 11126853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From clinical trials to clinical practice: what we know and do not know about beta-blockers and the heart.
    Feldman AM
    J Card Fail; 2000 Jun; 6(2 Suppl 1):34-9. PubMed ID: 10908096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blocker therapy for patients with ventricular heart failure and reduced systolic function.
    Giles TD
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):18-29. PubMed ID: 19667666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New therapeutic prospects in heart failure. ACE inhibitors and beta blockers].
    Capone A; Carfagna P; Paravati V; Bianco G; Battista M; Brandimarte C
    Recenti Prog Med; 1999 Mar; 90(3):136-42. PubMed ID: 10228352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta blocker treatment in heart failure.
    Carson PE
    Prog Cardiovasc Dis; 1999; 41(4):301-21. PubMed ID: 10362350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Blocker therapy in heart failure.
    Doughty RN
    Heart Fail Monit; 2000; 1(1):2-7. PubMed ID: 12634875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.
    Andersson B; Kjörk E; Brunlöf G
    Int J Cardiol; 2005 Oct; 104(3):257-63. PubMed ID: 16186053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of beta-blockers in patients with heart failure.
    Eichhorn EJ
    J Card Fail; 2000 Jun; 6(2 Suppl 1):40-6. PubMed ID: 10908097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of beta-blockers in chronic congestive heart failure.
    Mahanonda N; Samranthin M; Panyarachun S
    J Med Assoc Thai; 2000 Oct; 83(10):1240-7. PubMed ID: 11143491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure.
    Khattar RS
    Minerva Cardioangiol; 2003 Apr; 51(2):143-54. PubMed ID: 12783070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Elderly heart failure patients and the role of beta-blocker therapy].
    Middeljans-Tijssen CW; Jansen RW
    Tijdschr Gerontol Geriatr; 2006 Apr; 37(2):67-77. PubMed ID: 16704019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
    Jost A; Rauch B; Hochadel M; Winkler R; Schneider S; Jacobs M; Kilkowski C; Kilkowski A; Lorenz H; Muth K; Zugck C; Remppis A; Haass M; Senges J;
    Eur Heart J; 2005 Dec; 26(24):2689-97. PubMed ID: 16183697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failure.
    Witham MD; Gillespie ND; Struthers AD
    Age Ageing; 2004 Sep; 33(5):467-72. PubMed ID: 15217777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Refractory heart failure. Positive inotropes and beta blockers: alternative or complementary treatments?].
    Sabbadini G; Ciaccheri M; Castelli G; Sinagra G; Di Lenarda A
    Ital Heart J Suppl; 2002 Aug; 3(8):804-11. PubMed ID: 12407835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A continued role for beta-blocker therapy in heart failure.
    Korczyk DP; Doughty RN
    Heart Fail Monit; 2006; 5(1):15-9. PubMed ID: 16547531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of inpatient initiation of beta-blockers.
    Ventura HO
    Am Heart J; 2004 Dec; 148(6):944-50. PubMed ID: 15632876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
    Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.